Brief: Sangamo Therapeutics Q4 EPS USD -0.34

Sangamo Therapeutics

13/03/2024 12:05

Mar 13 (Reuters) - Sangamo Therapeutics Q4 net income USD -60.296 million.
* Q4 revenue USD 2.042 million
* Q4 operating income USD -62.059 million
* Q4 adjusted operating expenses USD 55.9 million
* Q4 operating expenses USD 64.1 million